- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£224.2b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£144.56
7D
1.1%
1Y
41.5%
Gilead Sciences
Market Cap: US$163.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$131.27
7D
3.9%
1Y
17.4%
Chugai Pharmaceutical
Market Cap: JP¥12.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,541.00
7D
-0.4%
1Y
5.6%
Orion Oyj
Market Cap: €10.1b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€72.00
7D
1.3%
1Y
13.6%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥58.9b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥130.58
7D
22.0%
1Y
41.6%
Xiamen Amoytop Biotech
Market Cap: CN¥23.9b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥58.53
7D
5.6%
1Y
-16.9%
PharmaResearch
Market Cap: ₩3.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩314,000.00
7D
-10.0%
1Y
-39.3%